
Diagnostic Medical Systems develops and manufactures medical imaging devices for digital radiology and bone densitometry.
dms-imaging.comCrawled Nov 11, 2026
The C-Arms Evo range includes image intensifier and flat panel detector models with varying power options.
Mobile Radiography Units
The Platinum dRF (FLEX) offers a portable detector for versatile radiography and fluoroscopy.
Focused on bringing ”intelligence to imaging” to the DMS Imaging’s software platform, ADAM, offers unique functions and improved workflow.
Press releases list contracts, revenue, and profitability updates from 2026.
DMS Imaging is present at the key international meetings that bring together medical imaging actors and experts : ECR, JFR, MEDICA, RSNA, WHX
DMS Imaging is a team of around one hundred people specialising in high technology for medical imaging.
The Mirror M project, supported under France 2030, aims to expand production of mobile X-ray devices.
An industrial strategy committee with high level personalities from the medical imaging field or specialized in business strategy.
DMS Imaging is referenced in the major French purchasing groups: UGAP, Resah and UniHA and is a member of the French Healthcare Association.
DMS Group is a French public company with a board of administration, including Samuel Sancerni, Jean-François Gendron, Marie-Laurence Borie, Julien Delpech, Vladislav Tcaci, Tim Yang, and Marko Järvinen.
DMS Imaging publishes its gender equality index (EGAPRO) score of 93/100.
DMS Imaging is a French industrial company specialized in digital radiology, with an international reach.
DMS Imaging is present at the key international meetings that bring together medical imaging actors and experts.
DMS Imaging is focused on the development, design and manufacturing of medical imaging systems.
DMS Group processes personal data collected through the website’s contact form.
Legal notice Website publisher The website www.dms-imaging.com is published by: DMS Group (DMS DIAGNOSTIC MEDICAL SYSTEMS)Public limited company (Société Anonyme – SA) with a share capital of €31,570,129.27Trade and Companies Register (RCS) Nîmes: 389 873 142Registered address: 9 Avenue du Canal Philippe LAMOUR — 30660 Gallargues-le-Montueux — FRANCEPhone: +33 4 66 29 09 07ISIN: FR0012202497 […]
Diagnostic Medical Systems (EPA:ALDMS) reports its voting rights and share distribution as of October 31, 2026. The filing provides transparency on ownership stakes and control structures for investors. No specific shareholder percentages or major changes are disclosed in the brief notice.
Nov 2026WebDisclosureNews article
DMS Group wins a contract to deliver 15 **M1 mobile X-ray units** to the **Greenland Health Authority**. The agreement supports healthcare mobility in remote regions, leveraging the company’s portable imaging solutions. The deployment aligns with Greenland’s efforts to improve medical diagnostics access.
Oct 2026Actusnews WireNews article
DMS Group recorded **EUR 7.9 million in consolidated revenue** for Q3 2026, marking a **28% decline** from the same period in 2025. The company’s financial performance reflects a downward trend in earnings compared to the prior year. No additional operational details or growth drivers were disclosed in the announcement.
Oct 2026actusnews.comNews article
DMS Group reports **EUR 22.1 million in H1 2026 revenue**, a **52% EBITDA increase to EUR 2.6 million (11.7% margin)**, and a return to **positive net income of EUR 0.5 million**. The company confirms its **2027 EBITDA margin target of 14%** amid strong financial performance.
Sep 2026BoursoramaNews article